Buchumschlag

BRAF‐V600E mutations in plasma and peripheral blood mononuclear cells correlate with prognosis of pediatric Langerhans cell histiocytosis treated with first‐line therapy

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Chan‐Juan Wang, Ting Zhu, Chen‐Zi Zhao, Hua Cui, Dong Wang, Zi‐Jing Zhao, Xiao‐Tong Huang, Hua‐Lin Li, Fei‐Fei Liu, Rui Zhang, Zhi‐Gang Li, Lei Cui
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Pediatric Blood & Cancer
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Trametinib Monotherapy in the Treatment of Pediatric Refractory/Relapse Langerhans Cell Histiocytosis
von: Wenqian Wang, et al.
Veröffentlicht: (2026)

Application of cell‐free DNA fungal polymerase chain reaction for invasive fungal disease evaluation in pediatric oncology and stem cell transplant patients
von: Lauren E. Kushner, et al.
Veröffentlicht: (2024)

BRAF/MEK inhibitors use to treat ventriculoperitoneal shunt‐associated ascites in pediatric low‐grade gliomas
von: Nisreen Amayiri, et al.
Veröffentlicht: (2024)

KIT ‐mutated pediatric core‐binding factor systemic mastocytosis‐acute myeloid leukemia treated with avapritinib and decitabine
von: Irtiza N. Sheikh, et al.
Veröffentlicht: (2024)

Incorporating innovative B‐cell targeting therapeutics into a combined‐modality bridging approach followed by timely consolidative haploidentical transplantation to salvage a pediatric patient with relapsed/refractory diffuse large B‐cell lymphoma
von: Yu‐Ju Chao, et al.
Veröffentlicht: (2024)

A Rare Case of Pediatric BRAF V600E‐Mutated Erdheim–Chester Disease With Isolated Central Nervous System Onset: Diagnosis, Treatment, and Efficacy Evaluation
von: Jing Ni, et al.
Veröffentlicht: (2026)

Access Program for Unapproved and Off‐Label Drug Use in Pediatric BRAF V600E‐Mutated Brain Tumors in Japan
von: Maya Suzuki, et al.
Veröffentlicht: (2025)

Weathering the storm when the end of the road is near: A qualitative analysis of supportive care needs during CAR T‐cell therapy in pediatrics
von: Angela Steineck, et al.
Veröffentlicht: (2024)

Successful haploidentical allogeneic stem cell transplantation for a pediatric chronic neutrophilic leukemia
von: Yanhui Luo, et al.
Veröffentlicht: (2024)

Cerebrospinal Fluid Liquid Biopsy Enables Targeted Therapy Without Tissue Diagnosis in Pediatric Low‐Grade Gliomas With BRAF V600E Mutation
von: Hannah Sultan, et al.
Veröffentlicht: (2026)

Fibrin‐associated diffuse large B‐cell lymphoma in a pediatric patient
von: Paige Reilly, et al.
Veröffentlicht: (2024)

Higher tumor mutational burden is associated with inferior outcomes among pediatric patients with neuroblastoma
von: Ya‐Hsuan Chang, et al.
Veröffentlicht: (2024)

Diagnosing a Case of Solitary Giant Molluscum Contagiosum Mimicking a Tumor in a Child: Using Dermoscopy and High‐Frequency Ultrasound
von: Zhao Zhang, et al.
Veröffentlicht: (2026)

Bone remodeling in survivors of pediatric hematopoietic stem cell transplantation: Impact of heavy resistance training
von: Lise Marie Krogh, et al.
Veröffentlicht: (2024)

Activity of the MEK inhibitor trametinib in a patient with a BRAF mutation persisting from T‐lymphoblastic lymphoma through lineage switch to CNS acute myeloid leukemia
von: Wallace Bourgeois, et al.
Veröffentlicht: (2024)

Social determinants of health predict health outcomes following pediatric allogeneic hematopoietic stem cell transplant
von: Kimberly L. Klages, et al.
Veröffentlicht: (2024)

The impact of levofloxacin prophylaxis on empiric intravenous antibiotic use in pediatric hematopoietic stem cell transplant recipients
von: Michael Prodanuk, et al.
Veröffentlicht: (2024)

Long-term stability of trastuzumab in plasma and whole blood samples stored under different conditions
von: Jonathan González-García
Veröffentlicht: (2019)

Multisystemic Pediatric Langerhans cell histiocytosis: a comprehensive clinico-pathological and BRAF V600E mutation study at autopsy
von: Gargi Kapatia
Veröffentlicht: (2020)

Comment on: “Challenging the Odds: Long‐Term Survival in Pediatric Diffuse Midline Glioma With H3 K27M and BRAF V600 Co‐Mutations Treated With Upfront Radiotherapy and Targeted Therapy”
von: Natália Dassi, et al.
Veröffentlicht: (2026)

Analysis of the intraoperative use of red blood cells and reserve index/transfusion at a University Hospital in Bogotá, Colombia
von: Katherine Caita-Rizo
Veröffentlicht: (2018)

Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: A single‐center case series
von: Ajibike Lapite, et al.
Veröffentlicht: (2024)

Monitoring pediatric CNS non‐germinomatous germ cell tumors via cerebrospinal fluid circulating tumor DNA
von: Yu‐Tong Zhang, et al.
Veröffentlicht: (2024)

Expansion of the Phenotype of Lymphatic Anomalies Caused by Somatic Activating BRAF Variant
von: Michael D. Fox, et al.
Veröffentlicht: (2025)

Diagnostic pitfalls in assessment of ferritin following CAR‐T‐cell therapy: Understanding the hook effect
von: Roa Harb, et al.
Veröffentlicht: (2024)

Alpha‐emitter therapy for pediatric relapsed metastatic pancreatic neuroendocrine tumor
von: Andrew Wahba, et al.
Veröffentlicht: (2024)

Body composition analysis using dual‐energy x‐ray absorptiometry in an Egyptian pediatric sickle cell disease cohort
von: Ahmed Maher Kaddah, et al.
Veröffentlicht: (2024)

Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR‐T cell therapy in KMT2A‐rearranged, therapy‐related acute lymphoblastic leukemia
von: Sanila Sarkar, et al.
Veröffentlicht: (2024)

Rare case of chronic lymphocytic leukemia in an adolescent treated with targeted therapy
von: Ariel Nash, et al.
Veröffentlicht: (2024)

Treatment of pediatric refractory or relapsed Epstein–Barr virus‐associated hemophagocytic syndrome with PD‐1 inhibitors
von: Shu‐Yi Guo, et al.
Veröffentlicht: (2024)

NRAS Q61R mutation drives elevated angiopoietin‐2 expression in human endothelial cells and a genetic mouse model
von: Patricia Pastura, et al.
Veröffentlicht: (2024)

Pre‐transplant glomerular hyperfiltration is not a risk factor for increased renal morbidity and mortality in pediatric stem cell transplant patients
von: Neil Sarkar, et al.
Veröffentlicht: (2024)

Early diagnosis of sickle cell retinopathy by using ocular coherence tomography in pediatric population (7–18 years) in central India
von: Pooja Soni, et al.
Veröffentlicht: (2024)

De novo germline TP53 mutation in a pediatric patient with Li–Fraumeni syndrome and diffuse peritoneal mesothelioma
von: Melek Yaman Ortaköylü, et al.
Veröffentlicht: (2024)

Brochure intervention to manage bothersome taste changes in pediatric patients receiving cancer therapy
von: Hadeel Hassan, et al.
Veröffentlicht: (2024)

Long‐term outcomes following proton therapy for pediatric spinal low‐grade glioma
von: Ryan J. Brisson, et al.
Veröffentlicht: (2024)

Novel mutation in KIF23 causing congenital dyserythropoietic anemia type III in patients who underwent allogeneic hematopoietic stem cell transplantation
von: Tomoko Fujikawa, et al.
Veröffentlicht: (2024)

Commercial markups on pediatric oncology drugs at 340B pediatric hospitals
von: Ian T. T. Liu, et al.
Veröffentlicht: (2024)

Targeting BCL11A through gene therapy in sickle cell disease: Will one size fit all or most?
von: Abdulrahman Alsultan
Veröffentlicht: (2024)

Efficacy and safety of azacitidine in pediatric patients with newly diagnosed advanced myelodysplastic syndromes before hematopoietic stem cell transplantation in the AZA‐JMML‐001 trial
von: Franco Locatelli, et al.
Veröffentlicht: (2024)